Unveiling the Challenges Managing Severe COVID 19 in Pregnant Women Insights from a UAE Case Series

Introduction

Key Findings from the Study

  • Location: Latifa Women and Children Hospital, UAE
  • Duration: Jan–June 2020
  • Subjects: Seven pregnant women with severe/critical COVID-19
  • Objective: Examine clinical features, treatment, and outcomes.

Common Clinical Presentations

  • Fever (6/7 patients)
  • Cough and breathing difficulties
  • High inflammatory markers and signs of cytokine storm
  • ARDS in 5 of 7 patients, requiring ventilation

Treatment Approaches

  • Medications Used:
    • Antivirals, steroids, anticoagulants
    • Pegylated interferon (5/7), Tocilizumab (1/7)
    • ECMO used in one critical case
  • Delivery:
    • All 5 third-trimester patients were delivered via emergency cesarean section due to maternal hypoxia
    • Neonatal outcomes were uniformly positive, with no COVID transmission detected

Outcomes

  • Maternal:
    • 1 maternal death due to multi organ failure
    • Early treatment with steroids and anticoagulants showed better recovery patterns
  • Neonatal:
    • All six neonates (including a twin set) were healthy, with negative COVID tests
    • Prematurity related jaundice resolved without complications

Broader Implications

Study Access

Takeaways

  • Pregnancy increases COVID-19 vulnerability due to physiological and immunological changes.
  • Early intervention using antivirals, steroids, and anticoagulants can improve maternal and neonatal outcomes.
  • Emergency cesarean delivery may be necessary in the face of maternal respiratory deterioration.
  • No vertical transmission observed supporting safe pregnancy care with rigorous infection control.

Call-to-Action

Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article